Drug: clopidogrel Quarter: 2016Q3
Total Records: 736 Number of Pages: 37
| DRUGNAME | PT | EventCount |
|---|---|---|
| CLOPIDOGREL BISULFATE. | Febrile neutropenia | 1 |
| CLOPIDOGREL BISULFATE. | Fluid retention | 1 |
| CLOPIDOGREL BISULFATE. | Foetal exposure during pregnancy | 1 |
| CLOPIDOGREL BISULFATE. | Gamma-glutamyltransferase increased | 1 |
| CLOPIDOGREL BISULFATE. | Gastrointestinal polyp haemorrhage | 1 |
| CLOPIDOGREL BISULFATE. | Haematuria | 1 |
| CLOPIDOGREL BISULFATE. | Haemodynamic instability | 1 |
| CLOPIDOGREL BISULFATE. | Haemolytic anaemia | 1 |
| CLOPIDOGREL BISULFATE. | Haemorrhage intracranial | 1 |
| CLOPIDOGREL BISULFATE. | Haemorrhagic stroke | 1 |
| CLOPIDOGREL BISULFATE. | Haemorrhoidal haemorrhage | 1 |
| CLOPIDOGREL BISULFATE. | Hepatic steatosis | 1 |
| CLOPIDOGREL BISULFATE. | Hepatitis cholestatic | 1 |
| CLOPIDOGREL BISULFATE. | Hepatitis toxic | 1 |
| CLOPIDOGREL BISULFATE. | High frequency ablation | 1 |
| CLOPIDOGREL BISULFATE. | Hypertension | 1 |
| CLOPIDOGREL BISULFATE. | Hypoaesthesia | 1 |
| CLOPIDOGREL BISULFATE. | Inflammatory marker increased | 1 |
| CLOPIDOGREL BISULFATE. | Intentional product misuse | 1 |
| CLOPIDOGREL BISULFATE. | Iron deficiency anaemia | 1 |
Total Records: 736 Number of Pages: 37